JPS50160487A - - Google Patents

Info

Publication number
JPS50160487A
JPS50160487A JP50026445A JP2644575A JPS50160487A JP S50160487 A JPS50160487 A JP S50160487A JP 50026445 A JP50026445 A JP 50026445A JP 2644575 A JP2644575 A JP 2644575A JP S50160487 A JPS50160487 A JP S50160487A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50026445A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS50160487A publication Critical patent/JPS50160487A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP50026445A 1974-03-05 1975-03-04 Pending JPS50160487A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7407352A FR2262962B1 (ja) 1974-03-05 1974-03-05

Publications (1)

Publication Number Publication Date
JPS50160487A true JPS50160487A (ja) 1975-12-25

Family

ID=9135822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50026445A Pending JPS50160487A (ja) 1974-03-05 1975-03-04

Country Status (12)

Country Link
US (1) US4136168A (ja)
JP (1) JPS50160487A (ja)
BE (1) BE826275A (ja)
CA (1) CA1052306A (ja)
CH (1) CH595106A5 (ja)
DE (1) DE2508396A1 (ja)
DK (1) DK141172B (ja)
ES (1) ES435323A1 (ja)
FR (1) FR2262962B1 (ja)
GB (1) GB1469901A (ja)
NL (1) NL7502623A (ja)
ZA (1) ZA751357B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68088B (ja) * 1978-02-16 1981-10-30 Science Union & Cie
CA1122527A (en) * 1979-05-15 1982-04-27 Karen K. Brown Influenza vaccine production in liquid cell culture
US4365187A (en) * 1980-05-15 1982-12-21 Rotron Incorporated Brushless D.C. motor
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029763A (en) * 1974-08-05 1977-06-14 Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing purified neuraminidase antigen and method of using the same

Also Published As

Publication number Publication date
NL7502623A (nl) 1975-09-09
GB1469901A (en) 1977-04-06
DK141172C (ja) 1980-07-14
CA1052306A (fr) 1979-04-10
DK141172B (da) 1980-01-28
US4136168A (en) 1979-01-23
ZA751357B (en) 1976-02-25
FR2262962B1 (ja) 1977-11-04
CH595106A5 (ja) 1978-01-31
DK85775A (ja) 1975-11-03
FR2262962A1 (ja) 1975-10-03
ES435323A1 (es) 1976-12-16
BE826275A (fr) 1975-09-04
AU7878175A (en) 1976-09-09
DE2508396A1 (de) 1975-10-23

Similar Documents

Publication Publication Date Title
FI752479A (ja)
FR2283082B1 (ja)
FR2278737B3 (ja)
FR2262962B1 (ja)
JPS50103965A (ja)
FR2333034B3 (ja)
FR2294165B1 (ja)
JPS5727286Y2 (ja)
AU495930B2 (ja)
JPS50101684U (ja)
JPS50117312U (ja)
JPS5227504Y2 (ja)
JPS50102116U (ja)
CH1703874A4 (ja)
BG19768A1 (ja)
BG20440A1 (ja)
BG20446A1 (ja)
BG20451A1 (ja)
BG20462A1 (ja)
BG20638A1 (ja)
BG19847A1 (ja)
BG20854A1 (ja)
BG20883A1 (ja)
BG20885A1 (ja)
BG20950A1 (ja)